在使用概率模型和治疗选择标准的网络元分析中生成治疗等级
Theodoros Evrenoglou1,2, Adriani Nikolakopoulou1,3, Guido Schwarzer1
1Institute of Medical Biometry and Statistics, https://ror.org/03vzbgh69Faculty of Medicine and Medical Center-University of Freiburg, Freiburg im Breisgau, Germany.
这项研究引入了在网络元分析 (NMA) 中对治疗方法的排名的新框架. 该方法提供可解释的治疗层次结构,考虑临床相关性和不确定性,改进现有方法.
科学领域:
- 生物统计学 生物统计学
- 临床流行病学临床流行病学
- 卫生技术评估 卫生技术评估
背景情况:
- 网络元分析 (NMA) 对于比较多种治疗方法至关重要.
- 现有的NMA排名方法因解释性差和不确定性处理而受到批评.
- 过度强调治疗效果的微小差异可能导致不理想的临床决策.
研究的目的:
- 开发一种新的概率框架,用于估计NMA中的治疗等级.
- 将基于最小值得差异 (SWD) 的临床相关治疗选择标准 (TCC) 纳入.
- 为现有的NMA排名方法提供一个更易于解释和更强大的替代方案.
主要方法:
- 开发了一个概率模型来估计基于TCC的治疗层次结构.
- 潜在的"能力"参数被分配给治疗方法,反映出它们对有益效果的倾向.
- 来自赫森矩阵的最大概率估计和非对称标准误差被用于参数估计.
- 开发了一个R包,mtrank,以实施拟议的方法.
主要成果:
- 新的框架产生了强大的和可解释的治疗等级大抑郁症 (抗抑郁药) 和糖尿病发病率 (抗高血压药).
- 与现有排名指标的一致程度各不相同,并且取决于NMA估计的准确性.
- 拟议的方法有效地解释了具体的TCC,并减轻了对小差异的过度解释.
结论:
- 开发的框架为NMA治疗排名提供了有价值的替代方案.
- 它通过考虑不确定性和临床相关性,使得更可靠,更具临床意义的治疗等级.
- 这种方法通过提供更清晰的治疗比较来支持更为明智的临床决策.
更多相关视频
09:50Impact Assessment of Repeated Exposure of Organotypic 3D Bronchial and Nasal Tissue Culture Models to Whole Cigarette Smoke
Published on: February 12, 2015
08:36Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
相关概念视频
Hazard Ratio
For example, in a clinical trial...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Pharmacodynamic Models: Additive and Proportional Drug Effect Model
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Strategies for Assessing and Addressing Confounding
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Comparing the Survival Analysis of Two or More Groups
